Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Empirical antibiotic treatment of sepsis in non-neutropenic patients: single agent or combination therapy?

× No keyword cloud information.

20 in total

Review 1. Ofloxacin. A reappraisal of its antimicrobial activity, pharmacology and therapeutic use.

Authors: P A Todd; D Faulds
Journal: Drugs Date: 1991-11 Impact factor: 9.546

2. New oral and parenteral quinolones. A summary.

Authors: H C Neu
Journal: Am J Med Date: 1989-11-30 Impact factor: 4.965

3. Imipenem versus tobramycin--antianaerobe antibiotic therapy in intra-abdominal infections.

Authors: D Poenaru; M De Santis; N V Christou
Journal: Can J Surg Date: 1990-10 Impact factor: 2.089

4. Vancomycin added to empirical combination antibiotic therapy for fever in granulocytopenic cancer patients. European Organization for Research and Treatment of Cancer (EORTC) International Antimicrobial Therapy Cooperative Group and the National Cancer Institute of Canada-Clinical Trials Group.

Authors:
Journal: J Infect Dis Date: 1991-05 Impact factor: 5.226

5. A randomized trial of high-dose ciprofloxacin versus azlocillin and netilmicin in the empirical therapy of febrile neutropenic patients.

Authors: P R Johnson; J A Liu Yin; J A Tooth
Journal: J Antimicrob Chemother Date: 1992-08 Impact factor: 5.790

6. Enterobacter bacteremia: clinical features and emergence of antibiotic resistance during therapy.

Authors: J W Chow; M J Fine; D M Shlaes; J P Quinn; D C Hooper; M P Johnson; R Ramphal; M M Wagener; D K Miyashiro; V L Yu
Journal: Ann Intern Med Date: 1991-10-15 Impact factor: 25.391

7. A comparison of imipenem to ceftazidime with or without amikacin as empiric therapy in febrile neutropenic patients.

Authors: K V Rolston; P Berkey; G P Bodey; E J Anaissie; N M Khardori; J H Joshi; M J Keating; F A Holmes; F F Cabanillas; L Elting
Journal: Arch Intern Med Date: 1992-02

8. Ceftazidime combined with a short or long course of amikacin for empirical therapy of gram-negative bacteremia in cancer patients with granulocytopenia.

Authors: Thierry Calandra; J Klastersky; H Gaya; M P Glauser; F Meunier; S H Zinner
Journal: N Engl J Med Date: 1987-12-31 Impact factor: 91.245

9. A randomized study of ceftazidime compared to ceftazidime and tobramycin for the treatment of infections in cancer patients.

Authors: V Fainstein; G P Bodey; L Elting; R Bolivar; M J Keating; K B McCredie; M Valdivieso
Journal: J Antimicrob Chemother Date: 1983-07 Impact factor: 5.790

10. Ceftazidime monotherapy for empiric treatment of febrile neutropenic patients: a meta-analysis.

Authors: J W Sanders; N R Powe; R D Moore
Journal: J Infect Dis Date: 1991-11 Impact factor: 5.226

2 in total

Review 1. Bacteraemia in the very old. Features and treatment.

Authors: L Leibovici
Journal: Drugs Aging Date: 1995-06 Impact factor: 3.923

Review 2. Sepsis: clinical dilemmas.

Authors: M J Murray
Journal: Yale J Biol Med Date: 1998 Nov-Dec

2 in total